GSK2194069
GSK2194069 is a potent and selective β-keto reductase (KR) domain inhibitor of fatty acid synthase (FASN), exhibiting an IC50 of 7.7 nM. It suppresses cancer cell proliferation by disrupting the FASN-catalyzed reduction of acetoacetyl-CoA with NADPH, making it a valuable tool for studying lipid metabolism and oncogenesis in vitro.
Product Specifications
CAS Number
1332331-08-4
Product Name Alternative
NADPH, Fatty Acid Synthase, Fatty Acid Synthase (FASN), FattyAcidSynthase, GSK2194069, GSK-2194069, GSK 2194069
Field of Research
Metabolism Research
Purity
98.75% (May vary between batches)
Solubility
DMSO:90 mg/mL (210.04 mM) ;10% DMSO+40% PEG300+5% Tween 80+45% Saline:3.3 mg/mL (7.7 mM)
Smiles
O=C (C1CC1) N1CC[C@@H] (Cc2n[nH]c (=O) n2-c2ccc (cc2) -c2ccc3occc3c2) C1
Molecular Formula
C25H24N4O3
Molecular Weight
428.48
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Guinea pig farnesyl diphosphate synthase (FDPS) ELISA Kit
Guinea pig farnesyl diphosphate synthase (FDPS) ELISA Kit
Guinea pig farnesyl diphosphate synthase (FDPS) ELISA Kit
Guinea pig farnesyl diphosphate synthase (FDPS) ELISA Kit
2-(Cyclohexylamino)-5-(phenylamino)-2,5-cyclohexadiene-1,4-dione
